Our results are aligned with previous studies, which showed that metformin could induce apoptosis and inhibit the growth of hepatocellular and breast cancer cells [57], by downregulating Bcl2 expression and upregulating Bax and P53 expression. Here, BCL2 is linked to breast carcinoma.